Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Systematic Review

Published on 12 Feb 2025

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lingling Zhao
Cheng Xu
Jiewen Deng
Yang Ni

Frontiers in Oncology

doi 10.3389/fonc.2025.1513394

609 views

Systematic Review

Published on 06 Feb 2025

Research progress of MRI-based radiomics in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiao-Yun Xie
Rong Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1420599

1,020 views

Original Research

Published on 06 Feb 2025

Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Taylor Davis
Katherine T. Decker
Dana Hosseini
Gayle Jameson
Erkut Borazanci

Frontiers in Oncology

doi 10.3389/fonc.2025.1495500

511 views

Original Research

Published on 05 Feb 2025

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ziting Peng
Jianhui Dong
Shuyao Tang
Jiaxu Shi
Tongdong Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1498887

397 views

Case Report

Published on 29 Jan 2025

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tara Seery
Lennie Sender
Omid Jafari
Frank Jones
Patricia Spilman
Sandeep B. Reddy
Patrick Soon-Shiong

Frontiers in Oncology

doi 10.3389/fonc.2025.1472714

1,223 views

Original Research

Published on 29 Jan 2025

Machine learning based predictive model and genetic mutation landscape for high-grade colorectal neuroendocrine carcinoma: a SEER database analysis with external validation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ruixin Wu
Sihao Chen
Yi He
Ya Li
Song Mu
Aishun Jin

Frontiers in Oncology

doi 10.3389/fonc.2025.1509170

764 views

Systematic Review

Published on 28 Jan 2025

Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yutong Jiang
Shangwen Qi
Rongrong Zhang
Ruixia Zhao
Yu Fu
Yuxuan Fang
Mingyi Shao

Frontiers in Oncology

doi 10.3389/fonc.2024.1483521

734 views

Editorial

Published on 27 Jan 2025

Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hu Jiaming
Zhang Minghui
Liu Huiqiang
Zhang Zongli
Xu Yunfei

Frontiers in Oncology

doi 10.3389/fonc.2024.1537218

551 views

Review

Published on 27 Jan 2025

Construction of nomogram model based on contrast-enhanced ultrasound parameters to predict the degree of pathological differentiation of hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shu-Min Lian
Hong-Jing Cheng
Hong-Jing Li
Hui Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1519703

413 views

Systematic Review

Published on 23 Jan 2025

A comparative analysis and survival analysis of open versus minimally invasive radical antegrade modular pancreatosplenectomy for pancreatic cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yating Zhou
Fei Xue

Frontiers in Oncology

doi 10.3389/fonc.2024.1513520

683 views

Original Research

Published on 20 Jan 2025

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qinxue Sun
Ziliang Wu
Xi Yin
Feng Li
Ri Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1483949

625 views

Systematic Review

Published on 17 Jan 2025

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wenxiao Lu
Tongsheng Zhang
Fengfei Xia
Xiangzhong Huang
Fulei Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1511210

896 views

Original Research

Published on 16 Jan 2025

Analysis of physical activity levels and influencing factors in cancer survivors after pancreaticoduodenectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qiuju Tian
Meiqin Xue
Leying Chen
Min Zhang
Weiyi Zhu
Beiwen Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1428884

584 views

Systematic Review

Published on 15 Jan 2025

Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Talaiti Tuergan
Aimitaji Abulaiti
Alimu Tulahong
Ruiqing Zhang
Zhongdian Yuan
Yanze Lin
Yingmei Shao
Tuerganaili Aji

Frontiers in Oncology

doi 10.3389/fonc.2024.1487198

864 views

Original Research

Published on 14 Jan 2025

Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiao Li
Yi Zhang
Zeyi Yan
Wenkai Jiang
Shaozhen Rui

Frontiers in Oncology

doi 10.3389/fonc.2024.1521788

944 views

Systematic Review

Published on 14 Jan 2025

Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tianyi Huang
Jing Chen
Lu Zhang
Rui Wang
Yiheng Liu
Cuihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1483196

610 views

Navigation group

Articles

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis

Research progress of MRI-based radiomics in hepatocellular carcinoma

Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

Machine learning based predictive model and genetic mutation landscape for high-grade colorectal neuroendocrine carcinoma: a SEER database analysis with external validation

Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis

Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II

Construction of nomogram model based on contrast-enhanced ultrasound parameters to predict the degree of pathological differentiation of hepatocellular carcinoma

A comparative analysis and survival analysis of open versus minimally invasive radical antegrade modular pancreatosplenectomy for pancreatic cancer: a systematic review and meta-analysis

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis

Analysis of physical activity levels and influencing factors in cancer survivors after pancreaticoduodenectomy

Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study

Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044

Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis